Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease

Peter P Toth1,2 1CGH Medical Center, Sterling IL, USA, 2Johns Hopkins University School of Medicine, Baltimore, MD, USA Abstract: Most individuals with type 2 diabetes mellitus have or will develop multiple independent risk factors for cardiovascular disease, particularly coronary artery disease (...

Full description

Bibliographic Details
Main Author: Toth PP
Format: Article
Language:English
Published: Dove Medical Press 2014-12-01
Series:Vascular Health and Risk Management
Online Access:http://www.dovepress.com/overview-of-saxagliptin-efficacy-and-safety-in-patients-with-type-2-di-peer-reviewed-article-VHRM